Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Abatacept (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms ABC
- 07 Jun 2017 Biomarkers information updated
- 26 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 26 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.